856935-35-8

Basic information

• Product Name: 3-(BROMOMETHYL)-4-FLUOROBENZONITRILE
• Synonyms: 5-CYANO-2-FLUOROBENZYLBROMIDE;3-(BROMOMETHYL)-4-FLUOROBENZONITRILE;BENZONITRILE, 3-(BROMOMETHYL)-4-FLUORO-
• CAS NO: 856935-35-8
• Molecular Formula: C₈H₅BrFN
• Molecular Weight: 214.03
• Mol File: 856935-35-8.mol

Chemical Properties

• Boiling Point: 274.389°C at 760 mmHg
• Flash Point: 119.747°C
• Appearance: /
• Density: 1.591g/cm³
• Vapor Pressure: 0.005mmHg at 25°C
• Refractive Index: 1.564
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-(BROMOMETHYL)-4-FLUOROBENZONITRILE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(BROMOMETHYL)-4-FLUOROBENZONITRILE(856935-35-8)
• EPA Substance Registry System: 3-(BROMOMETHYL)-4-FLUOROBENZONITRILE(856935-35-8)

Safety Data

• Hazardous Substances Data: 856935-35-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-(Bromomethyl)-4-fluorobenzonitrile is used as an intermediate in the synthesis of pharmaceuticals for its ability to participate in various organic reactions, contributing to the development of new drugs and medicinal compounds.
Used in Agrochemical Industry:
3-(Bromomethyl)-4-fluorobenzonitrile is used as an intermediate in the synthesis of agrochemicals, where its functional groups enable the creation of new compounds for agricultural applications, such as pesticides and herbicides.

InChI:InChI=1/C8H5BrFN/c9-4-7-3-6(5-11)1-2-8(7)10/h1-3H,4H2

Upstream product

• 185147-08-4 4-fluoro-3-methylbenzonitrile 
• 856931-47-0 4-fluoro-3-(hydroxymethyl)benzonitrile 
• 146328-87-2 2-fluoro-5-cyanobenzoic acid 
• 335256-12-7 5-cyano-2-fluorobenzoyl chloride 

Downstream Products

• 1021873-46-0 5-chloro-1-(5-cyano-2-fluorobenzyl)-2-imino-1,2-dihydropyridine-3-carboxamide hydrobromide 
• 1141474-47-6 tert-butyl N-(5-cyano-2-fluorobenzyl)-N-methyl-beta-alaninate 
• 927176-23-6 3-[(6-bromopyridin-2-yl)methyl]-4-fluorobenzonitrile 
• 1141475-62-8 tert-butyl N-(2-fluoro-5-{5-[2-(methoxymethyl)-2'-methylbiphenyl-4-yl]-1,2,4-oxadiazol-3-yl}benzyl)-N-methylglycinate 
• 1141473-18-8 N-(2-fluoro-5-{5-[2-(methoxymethyl)-2’-methylbiphenyl-4-yl]-1,2,4-oxadiazol-3-yl}benzyl)-N-methylglycine hydrochloride 
• 1126420-05-0 4-fluoro-3-(9-fluoro-10-methyl-6-oxo-6H-5-oxa-4,7-diaza-benzo[c]fluoren-7-ylmethyl)-benzonitrile 

Relevant articles and documents

N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS

A compound of formula (I), or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising the compound. The compound is an inhibitor of interactions between S100A9 and interaction partners such as RAGE, TLR4 and EMMPRIN and as such is useful in the treatment of disorders such as cancer, autoimmune disorders, inflammatory disorders and neurodegenerative disorders.

Synthesis and biological activity of 2H-quinolizin-2-one based p38α MAP kinase inhibitors

The development and synthesis of potent p38α MAP kinase inhibitors containing a 2H-quinolizin-2-one platform is described. Evolution of the 2H-quinolizin-2-one series from an early lead to solving off target activity and pharmacokinetic issues is also discussed.

HETEROBICYCLIC COMPOUNDS USEFUL AS P38 KINASE INHIBITING AGENTS

Compounds described by the chemical formula (I) or pharmaceutically acceptable salts thereof: (I) are inhibitors of p38 and are useful in the treatment of inflammation such as in the treatment of rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, gouty arthritis and other arthritic conditions; inflamed joints, eczema, psoriasis or other inflammatory skin conditions such as sunburn; inflammatory eye conditions including conjunctivitis; pyresis, pain and other conditions associated with inflammation.